Rankings
▼
Calendar
ADMA FY 2017 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena
ADMA
ADMA Biologics, Inc.
$4B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$23M
+113.5% YoY
Gross Profit
-$6M
-28.1% margin
Operating Income
-$39M
-172.7% margin
Net Income
-$44M
-192.3% margin
EPS (Diluted)
$-1.91
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$40M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$108M
Total Liabilities
$68M
Stockholders' Equity
$40M
Cash & Equivalents
$43M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$23M
$11M
+113.5%
Gross Profit
-$6M
$4M
-248.9%
Operating Income
-$39M
-$17M
-126.8%
Net Income
-$44M
-$20M
-124.2%
← Q4 2016
All Quarters
Q1 2017 →